Clinical Trial Update: Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating mafosfamide in patients with progressive or refractory meningeal tumors (brain/CNS), focusing on safety and dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• mafosfamide (mafosfamide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED